These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12410738)

  • 1. Magnesium status of patients with renal stones and its effect on urinary citrate excretion.
    Reungjui S; Prasongwatana V; Premgamone A; Tosukhowong P; Jirakulsomchok S; Sriboonlue P
    BJU Int; 2002 Nov; 90(7):635-9. PubMed ID: 12410738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary citrate excretion in patients with renal stone: roles of leucocyte ATP citrate lyase activity and potassium salts therapy.
    Tosukhowong P; Borvonpadungkitti S; Prasongwatana V; Tungsanga K; Jutuporn S; Dissayabutr T; Reungjui S; Sriboonlue P
    Clin Chim Acta; 2002 Nov; 325(1-2):71-8. PubMed ID: 12367768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo 31P-MRS assessment of muscle-pH, cytolsolic-[Mg2+] and phosphorylation potential after supplementing hypokaliuric renal stone patients with potassium and magnesium salts.
    Mairiang E; Hanpanich P; Sriboonlue P
    Magn Reson Imaging; 2004 Jun; 22(5):715-9. PubMed ID: 15172066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary excretion of citrate, glycosaminoglycans, magnesium and zinc in relation to age and sex in normal subjects and in patients who form calcium stones.
    Trinchieri A; Mandressi A; Luongo P; Rovera F; Longo G
    Scand J Urol Nephrol; 1992; 26(4):379-86. PubMed ID: 1292077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Some aspects of citrate metabolism in renal-stone patients from northeastern Thailand.
    Sriboonlue P; Prasongwatana V; Borvornpadoongkitti S; Suwantrai S
    J Med Assoc Thai; 1996 Nov; 79(11):737-43. PubMed ID: 8997014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of potassium-magnesium citrate supplementation on cytosolic ATP citrate lyase and mitochondrial aconitase activity in leukocytes: a window on renal citrate metabolism.
    Tosukhowong P; Tungsanga K; Phongudom S; Sriboonlue P
    Int J Urol; 2005 Feb; 12(2):140-4. PubMed ID: 15733107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary citrate excretion in idiopathic nephrolithiasis.
    Ratan SK; Bhatnagar V; Mitra DK; Basu N; Malhotra LK
    Indian Pediatr; 2002 Sep; 39(9):819-25. PubMed ID: 12368525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal excretion of citrate in patients with chronic renal failure or nephrolithiasis.
    Chen SM; Chung LC; Lee YH; Young TK
    J Formos Med Assoc; 1991 Jan; 90(1):41-7. PubMed ID: 1679108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of acute load of grapefruit juice on urinary excretion of citrate and urinary risk factors for renal stone formation.
    Trinchieri A; Lizzano R; Bernardini P; Nicola M; Pozzoni F; Romano AL; Serrago MP; Confalanieri S
    Dig Liver Dis; 2002 Sep; 34 Suppl 2():S160-3. PubMed ID: 12408462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reappraisal of the quantity and nature of renal calcifications and mineral metabolism in the magnesium-deficient rat. Effects of treatment with potassium citrate or the combination magnesium citrate and potassium citrate.
    Schmiedl A; Schwille PO; Bergé B; Markovic M; Dvorak O
    Urol Int; 1998; 61(2):76-85. PubMed ID: 9873245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of potassium and magnesium supplementations on urinary risk factors of renal stone patients.
    Jaipakdee S; Prasongwatana V; Premgamone A; Reungjui S; Tosukhowong P; Tungsanga K; Suwantrai S; Noppawinyoowong C; Maskasame S; Sriboonlue P
    J Med Assoc Thai; 2004 Mar; 87(3):255-63. PubMed ID: 15117041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of urinary excretion of Tamm-Horsfall protein in non-selected kidney stone formers and healthy subjects.
    Glauser A; Hochreiter W; Jaeger P; Hess B
    Nephrol Dial Transplant; 2000 Oct; 15(10):1580-7. PubMed ID: 11007825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
    Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
    J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of sodium bicarbonate upon urinary citrate excretion in calcium stone formers.
    Pinheiro VB; Baxmann AC; Tiselius HG; Heilberg IP
    Urology; 2013 Jul; 82(1):33-7. PubMed ID: 23602798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different dietary calcium intake and relative supersaturation of calcium oxalate in the urine of patients forming renal stones.
    Messa P; Marangella M; Paganin L; Codardini M; Cruciatti A; Turrin D; Filiberto Z; Mioni G
    Clin Sci (Lond); 1997 Sep; 93(3):257-63. PubMed ID: 9337641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between renal sodium-citrate cotransporter (hNaDC-1) gene polymorphism and urinary citrate excretion in recurrent renal calcium stone formers and normal controls.
    Okamoto N; Aruga S; Matsuzaki S; Takahashi S; Matsushita K; Kitamura T
    Int J Urol; 2007 Apr; 14(4):344-9. PubMed ID: 17470169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and dietary factors in urinary citrate excretion.
    Shah O; Assimos DG; Holmes RP
    J Endourol; 2005 Mar; 19(2):177-82. PubMed ID: 15798414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid peroxidation and its correlations with urinary levels of oxalate, citric acid, and osteopontin in patients with renal calcium oxalate stones.
    Huang HS; Ma MC; Chen CF; Chen J
    Urology; 2003 Dec; 62(6):1123-8. PubMed ID: 14665375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in urinary parameters after oral administration of potassium-sodium citrate and magnesium oxide to prevent urolithiasis.
    Kato Y; Yamaguchi S; Yachiku S; Nakazono S; Hori J; Wada N; Hou K
    Urology; 2004 Jan; 63(1):7-11; discussion 11-2. PubMed ID: 14751336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.